Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WF10 in Advanced HIV Disease
NCT00002152Phase 2Completed
- Sponsor
- OXO Chemie AG
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetrachlorodecaoxide in human immunodeficiency virus infection (HIV), sponsored by OXO Chemie AG. Status: completed.
02
Drugs
tetrachlorodecaoxide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002152.